Professor of Medicine
University of Miami
Miami, FL, United States
Dr. Alcaide is an Infectious Diseases specialist, Professor of Medicine, OB/GYN, and Public Health Sciences, Director of Clinical Research, the Infectious Diseases Research Unit, and the Miami Center For AIDS Research (CFAR) Clinical Core at the University of Miami Miller School of Medicine. Through these roles, she provides scientific and administrative oversight to multiple multidisciplinary research studies focused on HIV and other emerging infections including SARS-CoV-2. Dr. Alcaide is the principal investigator of large NIH funded studies in the US and internationally. In the US, she is the principal investigator of large study evaluating behavioral and biological factors that affect HIV acquisition among women, the Miami MACS/WIHS Combined Cohort Study (MWCCS), the Women HIV Cohort Study/ Study of Treatment And Reproductive outcomes (STAR cohort), and a study evaluating how co-infection with HIV and SARS-CoV-2 affect the development of new SARS-CoV-2 variants. These NIH funded cohorts are the largest US multisite studies evaluating the effect of HIV across the lifespan among men and women in the US, with focus on reproductive health, co-morbidities and coinfections. In international settings she is a coinvestigator of studies evaluating interventions to improve adherence to antiretrovirals in challenging populations such as pregnant women in South Africa and Zambia, and challenging patients in Argentina. As a result of her work, Dr. Alcaide has authored over 120 scientific publications. Dr. Alcaide also plays a critical role in mentoring junior investigators (including students, residents, fellows, and junior faculty), with focus on those we are women and of underrepresented groups. She is the director of the Miami Clinical and Translational Science Institute (CTSI) and the Miami CFAR Mentoring Programs, and she leads national and international mentoring initiatives. Her scientific contributions to the field of HIV utilizing multidisciplinary translational innovative research have the potential to reduce the impact of chronic health conditions and improve reproductive health for men and women living with HIV or at risk for HIV infection.
Disclosure(s): Discidium Biosciences: Board Member (Ongoing); Gilead Biosciences: Advisor/Consultant (Terminated, May 31, 2023); Senhwa Biosciences: Advisor/Consultant (Terminated, May 31, 2023)
270 - Live Long and Prosper: Managing Comorbidities in the HIV Clinic​
Saturday, October 14, 2023
3:15 PM – 4:30 PM US ET